CL.N Hits 20-Day High Amid Premiumization Focus
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 21 Nov 25
Shares of CL.N reached a 20-day high today, reflecting positive investor sentiment amid Procter & Gamble's ongoing premiumization strategy. The stock's upward momentum signals a potential shift in market dynamics as PG enhances its product portfolio with higher-value items, aiming to justify premium pricing and bolster profit margins. This technical breakout comes as competitors like Colgate-Palmolive face challenges in global growth, highlighting the competitive landscape in the consumer goods sector. Analysts remain optimistic about PG's earnings outlook, suggesting that its innovative marketing and product enhancements could sustain its market relevance despite recent share declines.
Analyst Views on CL
Wall Street analysts forecast CL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CL is 87.79 USD with a low forecast of 77.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
10 Buy
4 Hold
1 Sell
Moderate Buy
Current: 85.000
Low
77.00
Averages
87.79
High
95.00
Current: 85.000
Low
77.00
Averages
87.79
High
95.00
About CL
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
